Company information:
Hemogenyx Pharmaceuticals Plc (No: 08401609)
Address: 6TH FLOOR, 60 GRACECHURCH STREET, LONDON, EC3V 0HR, UNITED KINGDOM
Status: Active
Incorporated: 13-Feb-2013
Accounts Next Due: 30-Jun-2024
Next Confirmation Statement Due: 27-Feb-2025
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: MARC FELDMANN ( DOB: Dec-1944 From: Apr-2018 )
Current Director: PETER REDMOND ( DOB: Jul-1946 From: Jul-2015 )
Current Director: ALEXIS SANDLER ( DOB: Mar-1976 From: Oct-2017 )
Current Director: VLADISLAV SANDLER ( DOB: Aug-1965 From: Oct-2017 )
Current Secretary: BEN HARBER ( From: Jun-2023 )
Resigned Director: ADRIAN RICHARD THORPE BEESTON ( DOB: Aug-1969 From: Jul-2015 To: Apr-2018 )
Resigned Director: ROBIN WILLIAM CAMPBELL ( DOB: Sep-1956 From: Oct-2017 To: Jan-2019 )
Resigned Director: GEOFFREY GILBERT DART ( From: Feb-2013 To: Oct-2017 )
Resigned Director: TIMOTHY VINCENT LE DRUILLENEC ( DOB: Nov-1957 From: Nov-2014 To: Jul-2015 )
Resigned Director: TIMOTHY VINCENT LE DRUILLENEC ( DOB: Nov-1957 From: Oct-2017 To: Nov-2017 )
Resigned Director: LAWRENCE PEMBLE ( DOB: May-1988 From: Oct-2017 To: Nov-2018 )
Resigned Secretary: TIMOTHY VINCENT LE DRUILLENEC ( From: Nov-2013 To: Nov-2017 )
Resigned Secretary: ANDREW WRIGHT ( From: Nov-2018 To: Jun-2023 )
Persons of Significant Control:
Mrs Alexis Sandler, 5 Fleet Place, London, EC4M 7RD, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2017-10-05, Ceased: 2018-10-04)
Dr Vladislav Sandler, 5 Fleet Place, London, EC4M 7RD, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2017-10-05, Ceased: 2018-10-04)